Michael Verneris

Director of Bone Marrow Transplantation and Cellular Therapy · University of Colorado School of Medicine

Credentials: · · · · · ·

History

BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Heart, Lung, and Blood Institute · UG1
PI · $513.4K · National Marrow Donor Program
2024–2031
Characterizing Innate Immune Dysregulation in Tonsils of Individuals with Down Syndrome
National Heart, Lung, and Blood Institute · R01
Contact PI · $3M · University of Colorado Denver
2020–2025
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
National Cancer Institute · P01
Project lead · $1.5M · University of Minnesota
1997–2022
NK Cells, Their Receptors and Cancer Therapy
National Cancer Institute · P01
Project lead · $541.1K · University of Minnesota
2005–2021

T-Cell Depleted Double UCB for Refractory AML
Principal investigator · Terminated · Phase 2
Masonic Cancer Center, University of Minnesota
2011–2013
Influenza Vaccine Post Allogeneic Transplant
Principal investigator · Terminated
Masonic Cancer Center, University of Minnesota
2010–2011
Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
Principal investigator · Terminated · Phase 2
Masonic Cancer Center, University of Minnesota
2009–2011
MT2004-30: Tomotherapy for Solid Tumors
Principal investigator · Terminated · Phase 1
Masonic Cancer Center, University of Minnesota
2005–2016